litlas
ログインアカウント作成

Jacques P. Brown

1976–2025 年に発表

124
論文数
30,385
被引用数
86
h 指数
121
i10 指数

被引用数

Jacques P. Brown の年別被引用数1978 年: 被引用 1 件1981 年: 被引用 1 件1985 年: 被引用 5 件1986 年: 被引用 14 件1987 年: 被引用 7 件1988 年: 被引用 15 件1989 年: 被引用 5 件1990 年: 被引用 14 件1991 年: 被引用 14 件1992 年: 被引用 9 件1993 年: 被引用 10 件1994 年: 被引用 8 件1995 年: 被引用 4 件1996 年: 被引用 18 件1997 年: 被引用 10 件1998 年: 被引用 24 件1999 年: 被引用 35 件2000 年: 被引用 72 件2001 年: 被引用 75 件2002 年: 被引用 96 件2003 年: 被引用 124 件2004 年: 被引用 140 件2005 年: 被引用 157 件2006 年: 被引用 183 件2007 年: 被引用 171 件2008 年: 被引用 208 件2009 年: 被引用 175 件2010 年: 被引用 235 件2011 年: 被引用 194 件2012 年: 被引用 190 件2013 年: 被引用 152 件2014 年: 被引用 202 件2015 年: 被引用 217 件2016 年: 被引用 207 件2017 年: 被引用 229 件2018 年: 被引用 291 件2019 年: 被引用 808 件2020 年: 被引用 950 件2021 年: 被引用 779 件2022 年: 被引用 627 件2023 年: 被引用 404 件2024 年: 被引用 771 件2025 年: 被引用 351 件2026 年: 被引用 6 件1979〜1980 年は被引用が無いため表示していません1982〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,961 件、この内訳の 21.3%カナダ: 引用元論文 824 件、この内訳の 9%イギリス: 引用元論文 802 件、この内訳の 8.7%中国: 引用元論文 544 件、この内訳の 5.9%オーストラリア: 引用元論文 451 件、この内訳の 4.9%イタリア: 引用元論文 396 件、この内訳の 4.3%ドイツ: 引用元論文 348 件、この内訳の 3.8%フランス: 引用元論文 316 件、この内訳の 3.4%日本: 引用元論文 314 件、この内訳の 3.4%スイス: 引用元論文 307 件、この内訳の 3.3%ベルギー: 引用元論文 276 件、この内訳の 3%オランダ: 引用元論文 248 件、この内訳の 2.7%
0%21.3%その他 26.3%

機関

分野

  • Medicine80.9%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Engineering1%
  • Immunology and Microbiology1%
  • Health Professions0.9%
  • Neuroscience0.6%
  • その他3.2%

トピック

  • Bone health and osteoporosis research16.9%
  • Bone health and treatments11.9%
  • Bone Metabolism and Diseases7.9%
  • Bone and Joint Diseases5.5%
  • Hip and Femur Fractures4%
  • Parathyroid Disorders and Treatments2.5%
  • その他51.3%

共著者

全論文

検索で開く
  1. Romosozumab in Postmenopausal Women with Low Bone Mineral Density

    著者: Michael R. McClung, Andreas Grauer, Steven Boonen, Michael A. Bolognese, Jacques P. Brown, Adolfo Díez‐Pérez, Bente Langdahl, Jean‐Yves Reginster, José Zanchetta, Scott M. Wasserman, Leonid Katz, Judy Maddox, Yuching Yang, Cesar Libanati, Henry G. Bone - New England Journal of Medicine 2014 被引用: 1,235

  2. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

    著者: Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi, Jacques P. Brown, Roland Chapurlat, Steven R. Cummings, E. J. Czerwiński, Astrid Fahrleitner‐Pammer, David L. Kendler, Kurt Lippuner, Jean‐Yves Reginster, Christian Roux, Jorge Malouf, Michelle N. Bradley, Nadia Daizadeh, Andrea Wang, Paula Dakin, Nicola Pannacciulli, David W. Dempster, Socrates E. Papapoulos - The Lancet Diabetes & Endocrinology 2017 被引用: 961

  3. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

    著者: Bente Langdahl, Cesar Libanati, Daria B. Crittenden, Michael A. Bolognese, Jacques P. Brown, Nadia Daizadeh, Eva Dokoupilová, Klaus Engelke, Joel S. Finkelstein, Harry K. Genant, Stefan Goemaere, Lars Hyldstrup, Esteban Jódar-Gimeno, Tony M. Keaveny, David L. Kendler, Péter Lakatos, Judy Maddox, Jorge Malouf, Fabio Massari, José Fernando Molina, María Rosa Ulla, Andreas Grauer - The Lancet 2017 被引用: 467

  4. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy

    著者: Dora Liu, Alexandra Ahmet, Leanne M. Ward, Preetha Krishnamoorthy, Efrem D. Mandelcorn, Richard Leigh, Jacques P. Brown, Albert Cohen, Harold Kim - Allergy Asthma and Clinical Immunology 2013 被引用: 1,250

  5. Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

    著者: Aliya Khan, Archie Morrison, David A. Hanley, Dieter Felsenberg, Laurie K. McCauley, Felice O’Ryan, Ian R. Reid, Salvatore L. Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B. Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M. Cheung, Suzanne N. Morin, Basel Masri, Cyrus Cooper, Sarah Morgan, Barbara Obermayer‐Pietsch, Bente Langdahl, Rana Al Dabagh, Kelly Davison, David L. Kendler, George K.B. Sándor, Robert G. Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D. Pierroz, Riad A. Sulimani, Deborah Saunders, Jacques P. Brown, Juliet Compston, on behalf of the International Task Force on Osteonecrosis of the Jaw - Journal of Bone and Mineral Research 2014 被引用: 1,345

  6. Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension

    著者: Steven R. Cummings, Serge Ferrari, Richard Eastell, Nigel Gilchrist, Jens‐Erik Beck Jensen, Michael R. McClung, Christian Roux, Ove Törring, Ivo Valter, Andrea T Wang, Jacques P. Brown - Journal of Bone and Mineral Research 2017 被引用: 709

  7. Long-Term Treatment of Postmenopausal Osteoporosis

    著者: Jacques P. Brown - Endocrinology and Metabolism 2021 被引用: 200

  8. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

    著者: J. A. Kanis, Anders Odén, Olof Johnell, Helena Johansson, Chris De Laet, Jacques P. Brown, P. Burckhardt, Cyrus Cooper, Claus Christiansen, Steven R. Cummings, John A. Eisman, Saeko Fujiwara, Claus‐Christian Glüer, David Goltzman, D. Hans, M. A. Krieg, AZ La Croix, Eugène McCloskey, Dan Mellström, L. Joseph Melton, Huibert A. P. Pols, J. Reeve, Kerrie M. Sanders, Anne‐Marie Schott, Alan J. Silman, David Torgerson, Tjeerd van Staa, Nelson B. Watts, Noriko Yoshimura - Osteoporosis International 2007 被引用: 1,223

  9. A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX

    著者: Eugène McCloskey, Anders Odén, Nicholas C. Harvey, William D. Leslie, Didier Hans, Helena Johansson, Reinhard Barkmann, Stéphanie Boutroy, Jacques P. Brown, Roland Chapurlat, Petra J. M. Elders, Yuki Fujita, Claus‐C. Glüer, David Goltzman, Masayuki Iki, Magnus K. Karlsson, Andreas Kindmark, Mark A. Kotowicz, Norio Kurumatani, Timothy Kwok, Oliver Lamy, Jason Leung, Kurt Lippuner, Östen Ljunggren, Mattias Lorentzon, Dan Mellström, Thomas Merlijn, Ling Oei, Claes Ohlsson, Julie A. Pasco, Fernando Rivadeneira, Björn E. Rosengren, Elisabeth Sornay‐Rendu, Paweł Szulc, Junko Tamaki, John А. Kanis - Journal of Bone and Mineral Research 2015 被引用: 735

  10. Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study

    著者: Michael R. McClung, Jacques P. Brown, Adolfo Díez‐Pérez, Heinrich Resch, John Caminis, Paul Meisner, Michael A. Bolognese, Stefan Goemaere, Henry G. Bone, José Zanchetta, Judy Maddox, Sarah Bray, Andreas Grauer - Journal of Bone and Mineral Research 2018 被引用: 231

  11. Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment

    著者: Pascale Chavassieux, Roland Chapurlat, Nathalie Portero-Muzy, Jean‐Paul Roux, Pedro Aljama García, Jacques P. Brown, Cesar Libanati, Rogely Boyce, Andrea Wang, Andreas Grauer - Journal of Bone and Mineral Research 2019 被引用: 167

  12. Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates

    著者: Paul D. Miller, Nicola Pannacciulli, Jacques P. Brown, E. J. Czerwiński, Bettina S. Nedergaard, Michael A. Bolognese, Jorge Malouf, Henry G. Bone, Jean‐Yves Reginster, Andrea Singer, C. Wang, Rachel B. Wagman, Steven R. Cummings - The Journal of Clinical Endocrinology & Metabolism 2016 被引用: 234

  13. Skeletal responses to romosozumab after 12 months of denosumab

    著者: Michael R. McClung, Michael A. Bolognese, Jacques P. Brown, Jean‐Yves Reginster, Bente Langdahl, Yifei Shi, Jen Timoshanko, Cesar Libanati, Arkadi Chines, Mary Oates - JBMR Plus 2021 被引用: 73

  14. Current use of bone turnover markers in the management of osteoporosis

    著者: Jacques P. Brown, Andrew Don-Wauchope, Pierre Douville, Caroline Albert, Samuel D Vasikaran - Clinical Biochemistry 2022 被引用: 128

  15. Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass

    著者: Harry K. Genant, Klaus Engelke, Michael A. Bolognese, C. Mautalén, Jacques P. Brown, Chris Recknor, Stefan Goemaere, Thomas Fuerst, Yuching Yang, Andreas Grauer, Cesar Libanati - Journal of Bone and Mineral Research 2016 被引用: 141

  16. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

    著者: A. Papaioannou, Suzanne N. Morin, Angela M. Cheung, Stephanie A. Atkinson, Jacques P. Brown, Sidney Feldman, D.A. Hanley, Anthony B. Hodsman, S. A. Jamal, Stéphanie Kaiser, Brent Kvern, Kerry Siminoski, William D. Leslie - Canadian Medical Association Journal 2010 被引用: 1,756

  17. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

    著者: David L. Kendler, Christian Roux, Claude Laurent Benhamou, Jacques P. Brown, Michael Lillestol, Suresh Siddhanti, H Man, Javier San Martín, Henry G. Bone - Journal of Bone and Mineral Research 2009 被引用: 451

  18. Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression

    著者: Claudia Beaudoin, Lynne Moore, Mathieu Gagné, Louis Bessette, L.-G. Ste-Marie, Jacques P. Brown, Sonia Jean - Osteoporosis International 2019 被引用: 106

  19. Modeling-Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial

    著者: Erik Fink Eriksen, Roland Chapurlat, Rogely Boyce, Yifei Shi, Jacques P. Brown, S. Horlait, Donald Betah, Cesar Libanati, Pascale Chavassieux - Journal of Bone and Mineral Research 2020 被引用: 45

  20. Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial

    著者: Jacques P. Brown, Klaus Engelke, Tony M. Keaveny, Arkadi Chines, Roland Chapurlat, A. Joseph Foldes, Xavier Nogués, Roberto Civitelli, Tobias De Villiers, Fabio Massari, Cristiano A. F. Zerbini, Zhenxun Wang, Mary Oates, Christopher Recknor, Cesar Libanati - Journal of Bone and Mineral Research 2021 被引用: 73

  21. Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial

    著者: Jacques P. Brown, Richard L. Prince, Chad Deal, Robert R. Recker, Douglas P. Kiel, Luiz H de Gregorio, Peyman Hadji, Lorenz C. Hofbauer, José María Álvaro‐Gracia, Huei Wang, Matthew Austin, Rachel B. Wagman, Richard Newmark, Cesar Libanati, Javier San Martín, Henry G. Bone - Journal of Bone and Mineral Research 2008 被引用: 604

  22. A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

    著者: Michael R. McClung, MA Bolognese, Jacques P. Brown, Jean‐Yves Reginster, Bente Langdahl, Judy Maddox, Yifei Shi, Maria Rojeski, Paul Meisner, Andreas Grauer - Osteoporosis International 2020 被引用: 49

  23. Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario

    著者: Jacques P. Brown, Jonathan D. Adachi, Emil H. Schemitsch, Jean‐Éric Tarride, Vivien Brown, Alan Bell, Maureen Reiner, Thiago Oliveira, Ponda Motsepe-Ditshego, Natasha Burke, Lubomira Slatkovska - BMC Musculoskeletal Disorders 2021 被引用: 107

  24. Relationship Between Bone Mineral Density T-Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment

    著者: Serge Ferrari, Cesar Libanati, Celia J. F. Lin, Jacques P. Brown, Felicia Cosman, E. J. Czerwiński, LH de Gregόrio, Jorge Malouf-Sierra, J-Y. Reginster, A. Wang, RB Wagman, E. Michael Lewiecki - Journal of Bone and Mineral Research 2019 被引用: 107